Searched for
TARIFF IMPACTS ON NIFTY
Why did market fall today? Sensex falls 353 points, Nifty closes below 22,700 despite Jio’s solid debut; 4 triggers spooking D-StreetIn a challenging session, the Indian stock market dipped into the red due to increased oil prices and a slump in IT stocks. Jio Platforms’ ...- Rupee ends flat as stock slump, importer hedging erodes bounceThe Indian rupee held steady even as it initially surged, influenced by rising dollar demand from importers. However, the local stock marke...
- Oil Price Today (October 19): Crude oil dips 2% to $108 after hitting its highest levels since May. Here’s whyBrent crude futures dropped $1.80, or 1.64%, to $108.06 a barrel after settling at their highest level since May 19 on Friday. US West Texa...
- Rs 5 lakh crore worth FII outflows since 2024 capital gains tax hike wreak havoc on Dalal Street. Is a reversal on the cards?Foreign investors have sold over Rs 5 lakh crore of Indian equities since the 2024 capital gains tax hike, with outflows intensifying in 20...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Nifty 50 companies likely to log strong double-digit growth in Q2Revenue and net profit of Nifty 50 companies are projected to grow by nearly 20% year-on-year. Analysts note that performance is driven by ...
- Sensex falls over 20% in dollar terms in 2026 as weak sentiment, rupee drag returnsThe benchmark Sensex and Nifty have both experienced significant declines in dollar terms this year. Foreign investors have been less inter...
- KPIT Tech plunges 24% in 3 months as auto demand weakensKPIT Technologies faces a substantial 24% decline in stock value, predominantly due to obstacles in the automotive sector. The company's ne...
- RIL selloff wipes off Rs 4 lakh crore from market value as shares drop 21% in 2026 so far. Should you buy now?In 2026, Reliance Industries has seen a sharp decline of twenty-one percent in its share prices, wiping out an impressive four lakh crore r...
- $100 crude is an irritant, not a deal-breaker for India: Harsh Gupta MadhusudanWhile higher oil could pressure earnings and the rupee, he argues that the impact may be less severe than feared, with India’s growth backd...
- Largecap safety trade? 8 Nifty stocks test investor patience with losses for two yearsOver the past two years, eight Nifty stocks have experienced declines, with notable IT giants like TCS and Infosys pressured by shifts in c...
- Why Japan's 30-year high bond yields should worry Indian stock market investorsJapan’s 30-year high bond yields, hawkish US Federal Reserve policies, and rising crude oil prices are straining global liquidity. These fa...
- When volatility rises, will you panic or buy? Depends on the watchlist you build now: 5 large-cap stocks with upside potential of up to 32%Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Q1 earnings suggest an improving earnings cycle, but the recovery remains uneven across sectorsQ1 FY27 earnings signal an improving corporate earnings cycle with NSE500 profit growth at 21%, outpacing expectations. However, recovery r...
- ETMarkets Smart Talk | Nifty enters ‘very attractive’ zone as earnings improve: Union AMC’s Sanjay BembalkarDespite muted foreign flows and persistent geopolitical uncertainties keeping a lid on the broader market, corporate earnings have remained...
- Has Dalal Street's near term outlook improved? HSBC lists 4 headwinds, 3 tailwinds to watch out forHSBC Mutual Fund remains constructive on Indian equities, citing improving earnings, private capex, policy support and potential trade deal...
- Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investorsIndian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact ...
- Trump tariff tidal wave hits markets: Why India may dodge the trade bulletDonald Trump's recent tariffs have shaken global markets, but India remains relatively resilient, with its Sensex and Nifty showing minimal...
- Trump’s tariff gambit: 5 Indian sectors on high alert as April 2 deadline loomsAs Trump’s April 2 tariff decision looms, Indian markets brace for potential fallout. Mild tariffs could boost export-driven sectors like p...
Load More
